Xcout Intel
Imbria Pharmaceuticals, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Imbria Pharmaceuticals, Inc. among biotechnology companies — ranked by similarity to what Imbria Pharmaceuticals, Inc. actually does, not by market-cap band.
Subscribe to see Imbria Pharmaceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel cardiovascular therapies.
Imbria Pharmaceuticals, Inc. at a glance
Imbria Pharmaceuticals, Inc. is a biotechnology company headquartered in United States. It has raised at least $205.2M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round, Series B, closed in November 2025. Xcout tracks 12 named people at Imbria Pharmaceuticals, Inc., including Alvin Shih (Chief Executive Officer).
Imbria Pharmaceuticals, Inc. leadership
- Alvin ShihChief Executive Officer
- Komal JoshiExecutive Officer
- Pavan K. CheruvuBoard Chair
- Alvin ShihDirector
- Andrew LevinDirector
- James JanuzziDirector
6 more named people on record for Imbria Pharmaceuticals, Inc., with roles, board committees and tenure — see the full roster →
Imbria Pharmaceuticals, Inc. funding rounds
At least $205.2M raised across the 5 rounds on record (4 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | Undisclosed | 8 named | |
| Series B | $57.5M | 6 named | |
| Series B | $66.7M | 7 named | |
| SEC Form D filing | $40.7M | — | |
| SEC Form D filing | $40.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Imbria Pharmaceuticals, Inc. competitors
Ranked by semantic similarity — how close each company is to Imbria Pharmaceuticals, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Malvern, Pennsylvania, with additional operations in San Diego, California. The company focuses on the discovery and development of novel biopharmaceuticals for cardiovascular and other severe diseases.
Similar biotechnology company
Corteria Pharmaceuticals is a privately held biopharmaceutical company based in Paris, France, focused on developing first-in-class drugs for indications with high unmet medical need, particularly heart failure.
Similar biotechnology company
Centessa Pharmaceuticals LLC is a biotechnology research company headquartered in Boston, Massachusetts, United States. The company comprises leaders, innovators, and scientists dedicated to pursuing and developing transformational medicines for patients.
Similar biotechnology company
Imviva Biotech is a clinical-stage biotechnology company developing innovative therapies, including the TENACITY-01 CAR-T cell therapy clinical trial. The firm is associated with operations in Boston, Massachusetts, and works alongside other major biotechnology entities.
Similar biotechnology company
HeartBeat.bio is a biotechnology company founded in 2021 and located at the Vienna BioCenter in Austria, specializing in cardiac drug discovery. The company transforms cardiac drug recovery and development using innovative technologies originating from the Institute of Molecular Biotechnology (IMBA).
Similar biotechnology company
Checkmate Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on developing proprietary technology to stimulate the immune system to combat cancer.
Biotech
Iterion Therapeutics is a clinical-stage biopharmaceutical company headquartered in Houston, Texas. Founded in 2015, the company is dedicated to revolutionizing healthcare through novel drug discovery and innovation.
Similar biotechnology company
XyloCor Therapeutics is a clinical-stage biopharmaceutical company headquartered in King of Prussia, Pennsylvania, focused on developing novel gene therapies for advanced coronary artery disease. The company is dedicated to improving patient outcomes through innovative cardiovascular treatments.
Biotech
Ratio Therapeutics is a clinical-stage pharmaceutical company headquartered in Boston, Massachusetts. The company employs a suite of innovative technologies for the discovery and early clinical development of targeted radiopharmaceuticals.
Biotech
FogPharma, also known as Parabilis Medicines, is a clinical-stage biopharmaceutical and biotechnology research company headquartered in Cambridge, Massachusetts. The company is dedicated to creating novel therapeutics.
Similar biotechnology company
Cambrian BioPharma, Inc. is a biotechnology company headquartered in New York, United States, focused on developing therapeutics to extend human healthspan.
Similar biotechnology company
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Imbria Pharmaceuticals, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Imbria Pharmaceuticals, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →